Events

Agenda: The EU Pharma Package - Paul Ranson, EMIG Legal Advisor A registration link will be posted on here when we are closer to the webinar date.

Agenda: Data Protection update over the last 12 months - Andrew Gallie, VWV Data Protection lead. The registration link will be added closer to the webinar date.

Agenda: The Data Use and Access Act and the Cyber Security and Resilience Bill and its application to pharma - led by Andrew Gallie, VWV Data Protection lead. Registration link to follow closer to the webinar.

Agenda: Jargon-Busting on Legal Concepts. Kindly supported by VWV. Our speaker is Andrew White, Associate Fellow of Said Business School

Agenda: One of our speakers with be Lawrence Tallon, the new CEO at the MHRA

Agenda: If you wish to still attend this meeting please email jill.payne@emig.org.uk. Our keynote speaker is Dr. Lara Zibners, physician, educator, published author, angel investor and "accidental entrepreneur." With a broad background in clinical medicine and medical education in both the US and UK, Lara brings a unique understanding of the scientific, systematic and business challenges facing women's healthcare. This meeting is open to all EMIG members

Agenda: If you wish to book places at the dinner please email jill.payne@emig.org.uk

Agenda: Our speakers include: Tom Froggatt - CEO and Founder, Versapia Learning to Dance Through the Fire: Navigating the Future of Work; Nyambe “Yam” Sumbwanyambe - Founder, The Black Sherpa & The 29k Club Holding Space for Growth - How group mentoring unlocks clarity, confidence, and high performance; Catherine Garrod - Founder, Compelling Culture and author of Conscious Inclusion Inclusion in the New World

Agenda: Our speakers include: Tom Froggatt - CEO and Founder, Versapia Learning to Dance Through the Fire: Navigating the Future of Work; Nyambe “Yam” Sumbwanyambe - Founder, The Black Sherpa & The 29k Club Holding Space for Growth - How group mentoring unlocks clarity, confidence, and high performance; Catherine Garrod - Founder, Compelling Culture and author of Conscious Inclusion Inclusion in the New World

Agenda: New developments and opportunities for pharma companies in data, digital and AI. Please note that this meeting is now full. Please email jill.payne@emig.org.uk to be put on a waiting list.

Agenda: The professional development session at this event will focus on: Discounted Cash Flow (DCF). DCF’s form the back bone of any asset valuation and we have asked Dylan Schonke of Confucius Education to deliver an enlightening session on this essential calculation. Kindly supported by the Life Science team at law firm VWV

Agenda: The third in a series of roundtables hosted by the law firm VWV, to discuss Sustainable Buildings - To move or not to move, and where and how is the question? Speakers are David Roden from Niazi Roden and Emily Slupek from Savills. Chaired by Paul Gershlick.

Agenda: Agentic AI – what is it, and how are pharmaceutical companies using it to gain a competitive edge As the world of AI continues to evolve, Parth Khanna, CEO of ACTO – a fellow EMIG member - will provide insight into how Agentic AI is being used by pharmaceutical companies to optimise their sales & marketing efforts and gain that competitive edge.

Agenda: The Challenge - Unstructured data in NHS psychiatric EHRs Solution - Natural language processing for data structuring Benefit – longitudinal detailed patient records in Neuroscience, deep patient characterisation.

Agenda: This meeting is now fully subscribed. If you would like to join a waiting list please email jill.payne@emig.org.uk who will hold your name if registrants drop out. If you want to cancel your place, please email Jill also and she can reallocate your place.

Agenda: At this roundtable, we’ll explore how an organisation’s focus on sustainability can positively shift staff engagement. Employees are more motivated and connected to their employer when they see their company actively embracing sustainability.

Agenda: This event is now full. If you wish to see if there is a place available after drop-outs or would like to cancel your place, please email jill.payne@emig.org.uk who will help. A varied agenda, featuring the VPAG negotiations, NHS 10 Year Plan Update + ICB/commissioning/NHSE Update, Government Policy update and a panel session with a health system expert panel discussing NHS the NHS 10-year plan, balancing the present with the future, and the realities for life sciences.

Agenda: Join us for the first in a series of four interactive, invite-only roundtables designed specifically for pharma decision-makers and professionals who want to deepen their sustainability impact. This meeting is being organised by the law firm, VWV and so any queries should be addressed to them. Contact details are on the registration page.

Agenda: Our guest speaker, Hannah Collison will be speaking about Resilience, what it is and what can we do to develop our own resilience.

Agenda: Power Shift: Why Election ’26 Will Bring New Risks and Opportunities for Organisations in Wales. The presentation explores the significant political change with the election of a new Welsh Parliament with more members, elected under a different electoral process, what it means for the political parties, and the shape of the next Welsh Government.

Agenda: A session led by Helen Kane, Founder of One MSL, as we explore the Foundations of Field Medical Excellence, a critical meeting for anyone involved or interested in medical affairs. This event will focus on practical strategies to optimise the value and impact of field medical teams, helping to drive scientific engagement and business alignment. David Williams, CEO of Roar Intel and chair for the EMIG Medical Affairs Group

Agenda: Bob Fahy, Partner at VWV will review the provisions of the Employment Rights Bill, including recent developments arising from the Government's responses to consultation, the Commons Report Stage and Third Reading taking place on 11 & 12 March 2025, and discuss the potential impact from a ‘people and culture’ standpoint on life sciences workplaces.

Agenda: Legal Update: Supreme Court Ruling and Hot topics with an HR panel

Agenda: Even with strong research plans, many pharma and biotech companies face challenges in evidence generation and dissemination—leading to missed opportunities for product approval and market access. This webinar will cover: • Integrated Evidence Generation Planning – Minimising uncertainty in regulatory and HTA submissions • Strategic Publication Planning – Moving beyond a publication list to an impactful strategy • Good Publication Practices – Avoiding common pitfalls that can cause rejection and delays

Agenda: Newly hosted by hosted by Dr David Williams from ROAR Intel. Discussion about the future of the group, potential speakers etc.